Could a single infusion boost heart healing after a massive attack?
NCT ID NCT05211401
First seen Apr 24, 2026 · Last updated Jun 09, 2026 · Updated 9 times
Summary
This study tests whether a single dose of rituximab, a drug that calms the immune system, can improve heart function six months after a severe type of heart attack called anterior STEMI. About 372 adults who have had this heart attack will receive either rituximab or a placebo. The main goal is to see if the drug helps the heart pump better, as measured by MRI.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST ELEVATED MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cardiology department, Hôpital Bichat, AP-HP
RECRUITINGParis, 75018, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.